Skip to main content
EVGN
NASDAQ Life Sciences

Evogene Forms Joint Initiative with Tel Aviv University to Boost AI-Driven Drug Discovery

Tom Rudovsky · Reported by PR Newswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.425
Mkt Cap
$5.142M
52W Low
$0.37
52W High
$1.5
52W Position info
15% above low
Off High info
72% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

EVGN is trading near its 52-week low of $0.37 (15% above the low) on light trading volume (0.1× avg).

Summary

Evogene announced a joint initiative with Tel Aviv University's Blavatnik Center for Drug Discovery (BCDD) to accelerate AI-driven small-molecule drug discovery. This collaboration combines BCDD's experimental infrastructure with Evogene's ChemPass AI™ computational chemistry engine to bridge the gap between academic biological insights and drug candidate development. The partnership aims to broaden Evogene's pipeline of drug candidates, following recent financial challenges including a wider net loss and a dilutive ATM offering. This strategic move leverages Evogene's core AI technology to source and develop new therapeutic programs.

At the time of this announcement, EVGN was trading at $0.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $0.37 to $1.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.313 info
Change: -$0.0103 (-3%) info
Market Cap: $5.708M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.313 info
Change: -$0.0516 (-14%) info
Market Cap: $5.708M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.313 info
Change: -$0.0971 (-24%) info
Market Cap: $5.708M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.313 info
Change: -$0.1038 (-25%) info
Market Cap: $5.708M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.313 info
Change: -$0.0777 (-20%) info
Market Cap: $5.708M info